Boost Webinar – COVID-19 Vaccination: National Deployment and Vaccination Planning and Implementation

February 9, 2021

The Boost community is launching a new webinar series on COVID-19 vaccination. The webinar sessions will provide an opportunity for stakeholders to ask questions and share lessons learned on key aspects of COVID-19 vaccine introduction and administration. They will focus on key aspects of COVID-19 vaccination for global, regional, and national stakeholders. This first session (Feb 9) will focus on National Deployment and Vaccination Plan (NDVP) and allocation processes. Subsequent sessions will focus on key topics such as: costing/budgeting for COVID-19 vaccine introduction; vaccination strategies for priority groups and humanitarian buffer; generating acceptance and demand for COVID-19 vaccines supporting community led activities and reaching key influencers, etc.

Register here

You May Also Like

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More

Closing Immunisation Gaps Webinar Series/ Séries sur la Gestion des lacunes en matière de vaccination

Join the World Health Organization (WHO) and the Sabin Vaccine Institute’s Boost Community (Boost) on Thursday, October 24 at 3:00 PM Central European Time (CET) for a continuation of our multi-part webinar series, which will focus on Closing Immunisation Gaps. Please note that the series will continue weekly until Thursday, November 14. You can reference … Read More

Linked Webinar on One-dose HPV vaccination: Evidence, lessons learned and strategies, with experiences from Guyana and Estonia

Choosing or switching to a single dose HPV vaccination can simplify delivery and lower program costs. It can also help reduce the potential for supply shortages and alleviate delivery challenges such as those encountered during the COVID-19 pandemic. Whether countries are in the initial stages of introducing the HPV vaccine or considering a switch, they … Read More